As of 2026-10-05, the Relative Valuation of Adaptive Biotechnologies Corp (ADPT) is (11.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 28.35 USD, the upside of Adaptive Biotechnologies Corp based on Relative Valuation is -139.5%.
The range of the Relative Valuation is (12.90) - (10.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.1x - 43.7x | 34.0x |
| Forward P/E multiples | 17.7x - 26.0x | 21.8x |
| Fair Price | (12.90) - (10.44) | (11.20) |
| Upside | -145.5% - -136.8% | -139.5% |
| Date | P/E |
| 2026-10-02 | -70.62 |
| 2026-10-01 | -68.18 |
| 2026-09-30 | -71.99 |
| 2026-09-29 | -71.67 |
| 2026-09-28 | -71.02 |
| 2026-09-25 | -73.31 |
| 2026-09-24 | -73.66 |
| 2026-09-23 | -69.47 |
| 2026-09-22 | -69.90 |
| 2026-09-21 | -69.40 |
| 2026-09-18 | -71.27 |
| 2026-09-17 | -71.12 |
| 2026-09-16 | -68.93 |
| 2026-09-15 | -66.46 |
| 2026-09-14 | -61.73 |
| 2026-09-11 | -60.28 |
| 2026-09-10 | -60.36 |
| 2026-09-09 | -60.83 |
| 2026-09-08 | -60.63 |
| 2026-09-04 | -60.48 |
| 2026-09-03 | -61.20 |
| 2026-09-02 | -61.43 |
| 2026-09-01 | -60.63 |
| 2026-08-31 | -62.08 |
| 2026-08-28 | -62.75 |
| 2026-08-27 | -65.86 |
| 2026-08-26 | -65.16 |
| 2026-08-25 | -65.39 |
| 2026-08-24 | -63.64 |
| 2026-08-21 | -64.74 |
| 2026-08-20 | -63.37 |
| 2026-08-19 | -63.50 |
| 2026-08-18 | -61.18 |
| 2026-08-17 | -61.70 |
| 2026-08-14 | -61.63 |
| 2026-08-13 | -60.93 |
| 2026-08-12 | -62.90 |
| 2026-08-11 | -63.25 |
| 2026-08-10 | -63.40 |
| 2026-08-07 | -62.10 |
| 2026-08-06 | -58.79 |
| 2026-08-05 | -61.28 |
| 2026-08-04 | -61.15 |
| 2026-08-03 | -57.57 |
| 2026-07-31 | -56.22 |
| 2026-07-30 | -60.23 |
| 2026-07-29 | -56.20 |
| 2026-07-28 | -56.10 |
| 2026-07-27 | -56.15 |
| 2026-07-24 | -55.47 |